The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project-Reference-Cited by-同舟云学术

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project

Published:2009-04 Issue:4 Volume:20 Page:715-721
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Suzumiya J.,Ohshima K.,Tamura K.,Karube K.,Uike N.,Tobinai K.,Gascoyne R.D.,Vose J.M.,Armitage J.O.,Weisenburger D.D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/4/715/19445824/mdn696.pdf

Reference23 articles.

1. ATL and HTLV-I-related diseases;Takatsuki,1994

2. Adult T-cell leukaemia/lymphoma;Kikuchi,2001

3. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells;Karube;Br J Haematol,2004

4. The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma;Karube;Mod Pathol,2008

5. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87);Shimoyama;Br J Haematol,1991

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions;Current Treatment Options in Oncology;2023-06-10

2. A novel nomogram for predicting overall survival in peripheral T cell lymphoma patients;2023-04-27

3. Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia/lymphoma: From past to future;Journal of Clinical and Experimental Hematopathology;2023

4. Recent advances in T-cell lymphoid neoplasms;Experimental Hematology;2022-02

5. The Value and Relevance of T‐cell Lymphoma Registries;The Peripheral T‐Cell Lymphomas;2021-02-19